Raven Biotechnologies news from FierceBiotech
News
MacroGenics snags Raven Biotechnologies in buyout
Rockville, MA-based MacroGenics has struck a deal to buy Raven Biotechnologies, a South San Francisco-based developer of oncology drugs. MacroGenics said it plans to issue stock to complete the Read more...
Struggling VaxGen goes skeletal with cutbacks
With its planned merger involving Raven Biotechnologies on the rocks, a struggling VaxGen is Read more...
Get more Raven Biotechnologies coverage at:
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets